` LAB (Labiana Health SA) vs DAX Index Comparison - Alpha Spread

L
LAB
vs
D
DAX Index

Over the past 12 months, LAB has outperformed DAX Index, delivering a return of +19% compared to DAX Index's +4% growth.

Stocks Performance
LAB vs DAX Index

Loading...
LAB
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LAB vs DAX Index

Loading...
LAB
DAX Index
Difference
www.alphaspread.com

Performance By Year
LAB vs DAX Index

Loading...
LAB
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Labiana Health SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Labiana Health SA
Glance View

Market Cap
42.5m EUR
Industry
Pharmaceuticals

Labiana Health is a Spanish pharmaceutical company that makes medicines for both animals and people. Its business covers the development, manufacturing, and sale of finished medicines, with a strong focus on veterinary products such as treatments for pets and livestock, plus a smaller human health line. It also has industrial capabilities to produce medicines for other companies under contract, which adds a manufacturing-services side to the business. The company sells its own branded and private-label products to veterinarians, animal health distributors, pharmacies, and healthcare customers, depending on the product line. It earns money from selling finished medicines and from making products for third parties that need an experienced pharmaceutical manufacturer. That means Labiana sits both as a product company and as a behind-the-scenes producer in the supply chain. What makes its model different is the mix of animal health, human health, and contract manufacturing in one business. Veterinary medicine is often driven by recurring demand for treatments and prevention products, while contract manufacturing depends on long-term relationships and regulatory know-how. Labiana uses that pharmaceutical expertise across these channels rather than relying on just one type of customer or one market.

LAB Intrinsic Value
€8.56
Undervaluation 42%
Intrinsic Value
Price €5
L
Back to Top